Home » Topics » BioWorld Science

BioWorld Science
RSS

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Phase II begins for psoriasis vaccine

Nov. 20, 1997

Phase II results with T-cell receptor peptides in RA promising

Nov. 20, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

Nortran and Bridge Pharma to develop dermal anesthetics

Nov. 20, 1997

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nov. 20, 1997

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

Matritech: Q3 1997 highlights

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...